Richmond Investment Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Buy
2,234
+191
+9% +$42.4K 0.08% 161
2025
Q4
$467K Buy
2,043
+274
+15% +$62.4K 0.08% 147
2025
Q3
$410K Buy
1,769
+244
+16% +$49.7K 0.08% 155
2025
Q2
$283K Buy
+1,525
New +$283K 0.06% 169

Other funds holding ABBV

Richmond Investment Services's ABBV Position: Q1 2026 in Review

Richmond Investment Services increased its AbbVie (ABBV) stake by 9.3% in Q1 2026, buying an estimated $42.4K and bringing the position to 2,234 shares worth $486K. The position accounts for 0.08% of the portfolio, ranked #161.

Richmond Investment Services first reported a position in ABBV in Q2 2025 and has held it in 4 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Richmond Investment Services held 2,234 shares of AbbVie worth $486K as of Q1 2026.
  • Richmond Investment Services bought 191 AbbVie shares in Q1 2026, an estimated $42.4K.
  • AbbVie made up 0.08% of Richmond Investment Services's portfolio in Q1 2026, its #161 holding.
  • Richmond Investment Services first reported a position in AbbVie in Q2 2025 and has held it in 4 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Richmond Investment Services's 13F filing for Q1 2026, filed 29 Apr 2026.